Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Following migraine patients who also have a heart hole, to learn about treatment options

Observes people with migraine and patent foramen ovale to study their care and outcomes.

Plain-language title generated from the registry record
Registry title: Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Peking University Third HospitalBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Peking University Third Hospital
Trial code
NCT06953622
Record updated
1 May 2025
Original description
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.Read full original descriptionShow less

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.

Inclusion: Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3); Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography; Agree to participate in the study and sign the informed consent form.

Exclusion: Can not sign the informed consent form or cooperate with follow-up.

ClinicalTrials.gov NCT06953622